Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.

Walfridsson, H ; Walfridsson, U ; Nielsen, J Cosedis ; Johannessen, A ; Raatikainen, P ; Janzon, M ; Levin, L A ; Aronsson, M ; Hindricks, G and Kongstad Rasmussen, Ole LU , et al. (2015) In Europace 17(2). p.215-221
Abstract
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation (RFA) vs. antiarrhythmic drug therapy (AAD) as first-line treatment for patients with PAF. In this substudy, we evaluated the effect of these treatment modalities on the Health-Related Quality of Life (HRQoL) and symptom burden of patients at 12 and 24 months.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Europace
volume
17
issue
2
pages
215 - 221
publisher
Oxford University Press
external identifiers
  • pmid:25567068
  • wos:000351601600009
  • scopus:84922433201
  • pmid:25567068
ISSN
1532-2092
DOI
10.1093/europace/euu342
language
English
LU publication?
yes
id
cc7a94dc-67f8-4d48-a478-021b5ff55ed9 (old id 5040966)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25567068?dopt=Abstract
date added to LUP
2016-04-01 10:18:04
date last changed
2022-04-27 20:39:14
@article{cc7a94dc-67f8-4d48-a478-021b5ff55ed9,
  abstract     = {{The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation (RFA) vs. antiarrhythmic drug therapy (AAD) as first-line treatment for patients with PAF. In this substudy, we evaluated the effect of these treatment modalities on the Health-Related Quality of Life (HRQoL) and symptom burden of patients at 12 and 24 months.}},
  author       = {{Walfridsson, H and Walfridsson, U and Nielsen, J Cosedis and Johannessen, A and Raatikainen, P and Janzon, M and Levin, L A and Aronsson, M and Hindricks, G and Kongstad Rasmussen, Ole and Pehrson, S and Englund, A and Hartikainen, J and Mortensen, L S and Hansen, P S}},
  issn         = {{1532-2092}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{215--221}},
  publisher    = {{Oxford University Press}},
  series       = {{Europace}},
  title        = {{Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.}},
  url          = {{http://dx.doi.org/10.1093/europace/euu342}},
  doi          = {{10.1093/europace/euu342}},
  volume       = {{17}},
  year         = {{2015}},
}